do you take glp 1 daily What Should Eat on GLP-1 Medication? A Dietitian's Honest Guide What Really Happens When You

Jeffs orthopedic background means your care is guided by someone who understands how the body responds, recovers, and rebuilds from the inside out.Paired with guidance from a concierge dietician who helps align your nutrition with your sleep goals, the program at Formation is built to deliver real, measurable improvements rather than guesswork

Legitimate Research Directions: Some peptides DO have potential and are being properly studied: Thymosin Alpha-1: Immune support (approved in 35+ countries, trials in US) BPC-157: IF proper human trials ever happen LL-37: Antimicrobial applications Others: Many peptides have theoretical promise But ONLY if studied properly: Randomized controlled trials Safety studies FDA approval process Medical supervision The Problem: Most "wellness peptides" will NEVER go through this process because: They can't be patented (no profit incentive) Companies would rather sell in gray market Proper trials cost $100M+ If trials show they DON'T work, the market disappears So we're stuck in limbo: promising animal data, zero human data, aggressive marketing

Who Should NOT Consider Peptides Based on current evidence, I would advise against peptide use in the following individuals: Anyone with a current or recent cancer diagnosis Anyone with a strong family history of hormone-sensitive cancers (breast, ovarian, uterine, prostate, colorectal) Anyone with genetic mutations predisposing to cancer (BRCA1/2, Lynch syndrome, etc.) Anyone with active autoimmune disease or severe inflammatory conditions Pregnant or breastfeeding women Anyone who has not established foundational health practices Competitive athletes (most peptides are banned substances) Anyone seeking a "quick fix" rather than commitment to comprehensive health optimization If Considering Peptides: A Cautious Approach For patients who have established solid foundations, have no contraindications, understand the limitations of current evidence, and wish to explore peptides as a potential adjunct, here is the approach I might considerwith significant caveats: Lower-Risk Starting Point Topical GHK-Cu: This has the most established safety profile and documented benefits for skin health

NZB/NZW F1 lupus model A spontaneous model of lupus generated by crossing NZB and NZW mice, producing offspring (F1) that develop a female-biased, late-onset lupus-like disease

This makes iv glutathione treatment excellent for detox support

CJC-1295 + Ipamorelin doesnt work like a stimulant